Loading organizations...
Loading organizations...
1315 Capital operates as a healthcare-focused private equity firm, providing expansion and growth capital to commercial-stage companies. The firm strategically invests across four key healthcare verticals: healthcare services, pharma/medtech products, pharma/medtech outsourcing, and health & wellness. Their approach emphasizes deep domain expertise and hands-on engagement to drive operational improvements and strategic growth within their portfolio companies.
The firm was established in 2014 by seasoned healthcare investment veterans Adele Oliva and Michael Koby. They founded 1315 Capital based on the core insight that successful healthcare investing demands specialized expertise, alongside genuine collaboration with management teams. This foundational belief shaped their commitment to industry specialization, operational excellence, and authentic partnerships.
1315 Capital partners with leadership teams of commercial-stage healthcare businesses, supporting the development of scalable enterprises. Their overarching vision is to foster companies that not only deliver value for investors but also make a meaningful and positive impact on patients, physicians, and the wider healthcare system. The firm consistently seeks opportunities to accelerate growth and expand market reach.
Key people at 1315 Capital.
1315 Capital was founded in 2014 by Michael Koby (Co-Founder & Partner).
1315 Capital was founded in 2014 by Michael Koby (Co-Founder & Partner).
Key people at 1315 Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 13, 2022 | Nutrisense | $25.0M Series A | Jessica Hou | — |
| Aug 2, 2017 | Colorescience | $15.0M Series C | Adele C. Oliva | Greenspring Associates, HealthCare Ventures, Montreux Equity Partners |